We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

AbbVie Signs Term Sheet For Potential Global Settlement Of AndroGel Cases

(September 11, 2018, 2:33 PM EDT) -- CHICAGO — AbbVie Inc., Abbott Laboratories and two related entities have entered into a confidential term sheet regarding a potential global settlement of claims involving AndroGel testosterone replacement therapy, according to...
To view the full article, register now.